glp 1 and liver Mechanism of action for GLP-1R agonists. Primarily expressed in the Alimentary Pharmacology & Therapeutics |

Both are early enough in development that the published endpoints are surrogates body weight, HbA1c, liver fat measured over trial-length follow-up

For Eli Lilly, Mounjaro has taken off to the races extremely strong since its spring approval this year, surpassing market expectations by more than double

Not every patient will benefit, and those who do will benefit in different ways depending on their diagnoses, BMI, and which program they qualify for

Conditions or therapies that predispose patients to acidosis, such as kidney disease, severe pulmonary disease, status epilepticus, diarrhea, ketogenic diet, or certain drugs, may be additive to the bicarbonate lowering effects of topiramate